Perampanel May Help Control Seizures In Brain Tumors

What was studied

This paper combined results from 8 observational studies of perampanel in people with brain tumor-related epilepsy (BTRE). In total, 382 patients with brain tumors and seizures were included. About 57% were male, and the mean participant age across studies ranged from 43 to 58 years.

The review looked at seizure control, reported side effects, and whether there was any sign that the drug affected tumor progression. The studies reflected real-world clinical use rather than randomized clinical trials.

What they found

Across the studies, 42% of patients achieved seizure freedom, and 46% had a reduction in seizure frequency of at least half. Side effects were reported in 26% of patients, and most were mild to moderate. Tumor progression was reported in 39% of patients, and the review found no evidence that perampanel affected tumor behavior.

Limits of the evidence

The evidence is limited because all 8 studies were observational and not randomized. That means the review cannot show with certainty that perampanel itself caused the seizure improvements. The number of patients was modest, and the confidence intervals around the pooled estimates were fairly wide, suggesting uncertainty. Further prospective and controlled studies are needed to better define its role and long-term impact.

For families and caregivers

For families dealing with seizures caused by a brain tumor, this review suggests that perampanel may help some patients have fewer seizures, and some may become seizure-free. The side effects reported were mostly in line with the known safety profile of this medicine. Still, the available evidence is limited, so it is not possible to say how well it will work for any one person.

What to watch next

Further prospective and controlled studies are needed to better define the optimal role of perampanel and its long-term impact in people with brain tumor-related epilepsy.

Terms in this summary

systematic review

A study that collects and summarizes relevant research on a question using a planned method.

meta-analysis

A statistical method that combines results from several studies to estimate an overall result.

observational study

A study where researchers observe what happens without randomly assigning treatments.

brain tumor-related epilepsy

Seizures that occur in a person with a brain tumor.

AMPA receptor

A receptor in the brain involved in glutamate signaling, which can affect seizure activity.

seizure freedom

Having no seizures during the period being measured in a study.

oncologic progression

Worsening or progression of the tumor over time.

confidence interval

A range that shows how uncertain an estimate is; wider ranges mean less precision.